We are recruiting a technical assistant to join our work on dissecting the genetic and epigenetic basis of cancer and immune diseases using next generation sequencing. Our lab is based at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna, on the campus of one of the world’s largest hospitals and medical schools, pursuing an ambitious research program in molecular medicine.
At CeMM, we take career development of our staff seriously. For example, we will train the successful candidate in state-of-the-art technologies that are in high demand in academia and industry, and we encourage contribution to and co-authorship of scientific publications. Importantly, genomic medicine is a hot topic in Austria and internationally, creating a highly promising area for a career in biomedical research and applications.
The Lab (http://epigenomics.cemm.oeaw.ac.at/)
The Medical Epigenomics Lab at CeMM pursues an interdisciplinary and highly collaborative research program aimed at understanding the cancer epigenome and establishing its utility for precision medicine. The lab is internationally well connected and active in several fields:
Our lab is co-located with and maintains tight links to the Biomedical Sequencing Facility (BSF). The BSF is Austria’s first and leading center of expertise for next generation sequencing in biomedicine, jointly operated by the Medical University of Vienna and CeMM.
The Principal Investigator (http://cemm.at/research/groups/christoph-bock-group/)
Christoph Bock is a principal investigator at CeMM, a guest professor at the Medical University of Vienna, and the scientific coordinator of the Biomedical Sequencing Facility (BSF). He obtained his PhD at the Max Planck Institute for Informatics in 2008, followed by three years of postdoctoral research at the Broad Institute of MIT and Harvard, where he contributed to the NIH Roadmap Epigenomics project. He has been a principal investigator in BLUEPRINT (International Human Epigenome Consortium), and he co-founded Genom Austria, a citizen science project on the role of genomics in society. He has received several research awards, including the Max Planck Society’s Otto Hahn Medal (2009), an ERC Starting Grant (2016-2021), and the Overton Prize of the International Society of Computational Biology (2017).
The Institute (http://www.cemm.at/)
CeMM is an international research institute of the Austrian Academy of Sciences and a founding member of EU-LIFE. It has an outstanding track record of top-notch science (last five years: >10 papers in Nature/Cell/Science/NEJM, >25 papers in Nature/Cell sister journals) and medical translation. With just over a hundred researchers, CeMM provides a truly collaborative and personal environment, while maintaining critical mass and all relevant technologies. Research at CeMM focuses on cancer, inflammation, and immune disorders. CeMM is located at the center of one of the largest medical campuses in Europe, within walking distance of Vienna’s historical city center. A study by “The Scientist” placed CeMM among the top-5 best places to work in academia world-wide (http://the-scientist.com/2012/08/01/best-places-to-work-academia-2012). Vienna is frequently ranked the world’s best city to live. It is a United Nations city with a large English-speaking community. The official language at CeMM is English, and more than 40 different nationalities are represented at the institute.
Please apply online (https://cemm.jobbase.io/job/132eh0y2) with cover letter, CV, academic transcripts, and contact details of three referees. Applications will be reviewed on a rolling basis. Any application received by 15 September 2017 will be considered. Start dates are flexible.